Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
An Exploration of Outcomes in Patients with Cardiogenic Shock treated with Extracorporeal Membrane Oxygenation.
FY 2024-25
Summary
Extracorporeal membrane oxygenation (ECMO) is an advanced treatment for cardiogenic shock (CS), a highly heterogenous condition with a high mortality rate. Evidence supporting the use of veno-arterial (VA) ECMO is sparse, yet it still remains a treatment option for CS patients deteriorating on medical therapy. In 2017, the University Health Network (UHN) assessed VA-ECMO patient outcomes and developed new policies, such as establishing a multidisciplinary team and outlining specific selection criteria. We hypothesize that changes in patient selection and utilization of a multidisciplinary ECMO team would lead to improved clinical outcomes and a reduction in adverse events. We will first investigate VA-ECMO patient outcomes at UHN using data from an international ECMO registry. By analyzing patient demographic variables and clinical parameters, we can identify factors predictive of survival. By comparing the historical (2014-2017) to the contemporary cohort (2018-2024), we can determine if changes to our approach led to improved survival. Secondly, we will investigate the effectiveness of VA-ECMO to improve survival in specific cohorts of CS patients. We will use data from the UHN CS registry to perform a retrospective pseudo-trial in CS patients with different interventions with the intent to develop a predictive model. Our research has the potential to directly impact clinical decision-making for initiation of mechanical circulatory support in CS patients with VA-ECMO at UHN. CS patients still exhibit significant morbidity and mortality, and with personalized treatment based on etiology we can alleviate this burden.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529727
Name
Fung Nicole L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
An Exploration of Outcomes in Patients with Cardiogenic Shock treated with Extracorporeal Membrane Oxygenation.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiogenic Shock; Clinical Predictors; Ecmo; Mechanical Circulatory Support; Multidisciplinary Team; Outcomes; Predictive Modelling; Pseudotrial; Quality Improvement; Survival
Abstract
Extracorporeal membrane oxygenation (ECMO) is an advanced treatment for cardiogenic shock (CS), a highly heterogenous condition with a high mortality rate. Evidence supporting the use of veno-arterial (VA) ECMO is sparse, yet it still remains a treatment option for CS patients deteriorating on medical therapy. In 2017, the University Health Network (UHN) assessed VA-ECMO patient outcomes and developed new policies, such as establishing a multidisciplinary team and outlining specific selection criteria. We hypothesize that changes in patient selection and utilization of a multidisciplinary ECMO team would lead to improved clinical outcomes and a reduction in adverse events. We will first investigate VA-ECMO patient outcomes at UHN using data from an international ECMO registry. By analyzing patient demographic variables and clinical parameters, we can identify factors predictive of survival. By comparing the historical (2014-2017) to the contemporary cohort (2018-2024), we can determine if changes to our approach led to improved survival. Secondly, we will investigate the effectiveness of VA-ECMO to improve survival in specific cohorts of CS patients. We will use data from the UHN CS registry to perform a retrospective pseudo-trial in CS patients with different interventions with the intent to develop a predictive model. Our research has the potential to directly impact clinical decision-making for initiation of mechanical circulatory support in CS patients with VA-ECMO at UHN. CS patients still exhibit significant morbidity and mortality, and with personalized treatment based on etiology we can alleviate this burden.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fung, Nicole L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~